Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

T Cell Types and Functions01:24

T Cell Types and Functions

2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.5K
Overview
83.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

16.0K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor function.

bioRxiv : the preprint server for biology·2026
Same author

Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor.

Nature communications·2026
Same author

CART-007: a license to kill.

Blood·2025
Same author

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Blood advances·2025
Same author

Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapy.

Stem cells translational medicine·2025
Same author

CD7 CAR-T: a bridge to transplant in AML.

Blood·2025

相关实验视频

Updated: Jan 17, 2026

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

1.7K

到九点:IL-9可以促进T细胞功能.

Elizabeth Wickman1, Maksim Mamonkin1

  • 1Columbia Initiative in Cell Engineering and Therapy, Columbia University Irving Medical Center, New York, NY, USA; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA.

Immunity
|January 14, 2026
PubMed
概括
此摘要是机器生成的。

干白素-9 (IL-9) 在T细胞中的信号增强了它们在固体癌症模型中的持久性和抗瘤能力,扩大了其已知的作用,超出了对寄生虫和过敏的免疫力.

更多相关视频

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.9K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

15.2K

相关实验视频

Last Updated: Jan 17, 2026

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

1.7K
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.9K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

15.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 癌症生物学 癌症生物学
  • T细胞生物学T细胞生物学

背景情况:

  • 介质蛋白-9 (IL-9) 传统上被认为是其在抗虫和过敏免疫反应中的作用.
  • 在癌症免疫的背景下,在T细胞内IL-9信号传递的特定功能不太清楚.

研究的目的:

  • 在固体癌症模型中,研究整合T细胞内的IL-9信号传导对其功能的影响.
  • 探索针对IL-9用于癌症治疗的新型治疗策略.

主要方法:

  • 利用固体癌症模型来评估T细胞的反应.
  • 研究了调节T细胞IL-9信号通路的影响.

主要成果:

  • 证明IL-9信号增强了固体瘤中T细胞的持久性.
  • 表明IL-9信号改善T细胞的抗瘤功能.
  • 确定了IL-9在促进抗癌免疫力方面的新型作用.

结论:

  • 在T细胞中的IL-9信号传递是增强固体癌症抗瘤免疫力的关键因素.
  • 准IL-9通路是改善癌症免疫疗法的有希望的途径.